The Faster Clinical Trials Act would create an FDA Center for Clinical Trial Innovation and aims to cut trial costs and enrollment time by at least 30%.
|Articles|February 11, 2014
Business and People February 2014
Author(s)Hannah Richter
Industry news focusing on the people and organizations who work in the clinical trials profession.
Advertisement
People
Aptuit (Greenwich, CT) announced the appointment of Jonathan Goldman, MD, as Chief Executive Officer, completing the company’s senior management leadership team.
Rho (Chapel Hill, NC) announced the appointment of Kristen Harrington, Principal Programmer/Analyist, Rho, as the 2016 Conference Chair and member of the Executive Committee for the Southeastern SAS User’s Group (SESUG). SESUG is a Regional Users Group for users of SAS software.
Celerion (Lincoln, NE) announced the appointment of John Horkulak as Executive Director, Eurasian Site Operations. Horkulak will lead the efforts to further expand the company’s early phase patient capabilities in Europe and Asia.
CTI Clinical Trial and Consulting Services (Cincinnati, OH) announced the addition of David Facklam, MS, as Senior Director, Regulatory and Scientific Affairs. CTI also announced the promotion of William Aronstein, PhD, MD, FACP, to Vice President, Medical Affairs.
DAC Patient Recruitment Services (Dallas, TX and Boston, MA) announced the return of Dan McDonald as Director of Business Development.
INC Research (Beijing, China) announced three key management appointments to enhance its growing presence and clinical R&D team in Japan. Hiromi Wakita, PhD, has joined as General Manager and Clinical Director, and will lead the company’s operations in Japan. Hiroshi Uoji was appointed Regulatory and Safety Director for Japan, and Shinichi Sato, who joined as Project Director, CNS Clinical Development in Japan.
ERT (Philadelphia, PA) announced the expansion to its cardiac safety, respiratory, and Clinical Outcome Assessment/electronic COA consulting group with the addition of Matthew Reaney, Scientific and Regulatory Consultant.
ICON plc (Dublin, Ireland) announced the addition of Steve Cutler, PhD, as Chief Operating Officer. Within Cutler’s team, Nuala Murphy, PhD, has been appointed President, ICON Clinical Services, and Jim Miskel has been appointed Executive Vice President & General Manager, ICON Laboratory Services. Icon also announced the election of Chief Executive, Ciaran Murray, as Chairman of the Association of Clinical Research Organizations.
Association of Contract Research Organizations (ACRO INDIA) (New Delhi, India) announced the unanimous election of D.A. Prasanna as Chairman of the Association.
Awards
Almac (Craigavon, Ireland) announced their team’s recognition at the Irish Laboratory Awards, by winning “Laboratory Team of the Year.” The awards, the first of their kind in Ireland, were held to recognize the success and achievements of Ireland’s internationally renowned scientists in areas including innovation, leadership, and collaboration, and focus on the ongoing work of Irish scientists to grow and develop sustainable, globally competitive scientific research. (IMAGE)
Clinical Research Advantage (CRA) (Tempe, AZ) announced that three company departments received national recognition in the 2013 Best in Biz Awards. CRA’s Business Development department received the Silver Award for Business Development Department of the Year. CRA’s Technology Department received the Bronze Award for Technology Department of the Year. And CRA’s Finance Department received the Silver Best in Biz Award for Finance Department of the year.
The Center for Information and Study on Clinical Research Participation (CISCRP) (Boston, MA) received an Award of Excellence for Best Practice from the Health Improvement Institute’s 2013 Human Research Protection Awards.
PRA (Raleigh, NC) announced it was a finalist in the category of Best Life Science Contract Research Organization of the Year award for the 4th Annual BioPharma Asia Industry Awards. Last year, PRA was voted “Best CRO” for the 3rd Annual awards. This year’s winner will be selected after February 28th.
Company News
Greenphire
(King of Prussia, PA) announced a significant milestone: it has officially executed one million payments through its clinical payment platform.
New Facilities
SG Research International (SGRI) (Wyckoff, NJ) announced that it is opening a new office in Beijing, China as part of an effort to expand its business there.
Advertisement
Related to this article
Standardized measurement across five oncology centers found that clinical research coordinators rated eSource-enabled workflows positively (Overall Mean Satisfaction 5.79 of 7), with reduced manual entry and electronic data transfer earning strong marks, while perceived reduction in sponsor and monitor queries lagged as the one domain below threshold.
In this video interview, Rajneesh Patil, global head of AI, digital, and innovation in clinical development at Syneos Health, describes the industry’s trajectory toward a unified intelligence orchestration environment—and explains why the future isn’t one model that knows everything, but a trusted system that brings the right evidence to the right human decision.
In today’s ACT Brief, we examine how sites can avoid both fear-driven and overly aggressive AI adoption, why community-based research needs sustained financial investment, and why patient access matters more than organizational size.
Pacing obesity trial enrollment, anchoring eligibility to stable real-world therapies, and building site and physician relationships improve retention and data quality more than aggressive recruitment or restrictive exclusion criteria do.
In this video interview, Rajneesh Patil, global head of AI, digital, and innovation in clinical development at Syneos Health, argues that CROs must act as orchestrators rather than aggregators—and that the real test of any AI ecosystem is whether it reduces sponsor coordination burden or just hands it back to them.
Syneos Health and Optum outline a joint model for trial planning, recruitment and site access, with no financial terms or timelines disclosed.
AstraZeneca and Oracle Outline AI Collaboration for Clinical Trial Recruitment and Safety Monitoring
What sponsors and sites should know about the AstraZeneca-Oracle AI collaboration on trial recruitment, safety monitoring and data governance.
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Where the Industry Is Headed as Clinical, Operational, and Real-World Data Connect
2
Where AI Governance in Clinical Development Falls Short
3
Building Standardized Evidence for eSource-Enabled Clinical Trials: Multi-Site Validation of a Clinical Research Coordinator Satisfaction Methodology
4
Syneos Health, Optum Partner on Adaptive Clinical Development Model
5